Overview Financials News + Filings Key Docs Charts Ownership Insiders |
AZIYO BIOLOGICS, INC. (AZYO)
|
Add to portfolio |
|
|
Price: |
$6.75
| | Metrics |
OS: |
16.2
|
M
| |
|
|
Market cap: |
$110
|
M
| |
|
|
Net debt:
|
$15.6
|
M
| |
|
|
EV:
|
$125
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($20.4)
|
M
| |
|
|
EBIT
|
($24.2)
|
M
| |
|
|
EPS |
($2.27)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
Revenues | 49.2 | 47.4 | 42.7 | 42.9 | |
Revenue growth | 3.8% | 11.0% | -0.5% | | |
Cost of goods sold | 30.0 | 28.4 | 22.1 | 23.1 | |
Gross profit | 19.2 | 19.0 | 20.6 | 19.8 | |
Gross margin | 39.1% | 40.1% | 48.2% | 46.1% | |
Sales and marketing | 20.2 | 18.8 | 17.6 | 16.2 | |
Research and development | 8.9 | 9.3 | 6.0 | 2.4 | |
General and administrative | 16.6 | 13.7 | 10.6 | 9.6 | |
EBITA | -23.1 | -19.4 | -10.2 | -8.4 | |
EBITA margin | -47.1% | -40.9% | -23.9% | -19.6% | |
Amortization of intangibles | 3.4 | 3.4 | 3.4 | | |
EBIT | -26.5 | -22.8 | -13.6 | -8.4 | |
EBIT margin | -54.0% | -48.0% | -31.9% | -19.6% | |
Pre-tax income | -32.9 | -24.8 | -21.8 | -11.9 | |
Income taxes | 0.0 | 0.1 | 0.0 | 0.0 | |
Net income | -32.9 | -24.8 | -25.3 | 0.0 | |
Net margin | -66.9% | -52.4% | -59.4% | 0.0% | |
|
Diluted EPS | ($2.38) | ($2.38) | ($8.88) | ($18.48) | |
Shares outstanding (diluted) | 13.8 | 10.4 | 2.9 | 0.0 | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|